CASP4
Basic information
Region (hg38): 11:104942866-104969366
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CASP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 2 | 3 |
Variants in CASP4
This is a list of pathogenic ClinVar variants found in the CASP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-104944766-A-G | not specified | Uncertain significance (Apr 07, 2022) | ||
11-104944774-G-GA | Benign (Jul 31, 2018) | |||
11-104944851-C-T | not specified | Uncertain significance (Apr 06, 2024) | ||
11-104947136-T-G | not specified | Uncertain significance (Oct 25, 2022) | ||
11-104948538-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
11-104948572-C-T | not specified | Uncertain significance (Oct 24, 2023) | ||
11-104948606-C-A | Benign (Dec 31, 2019) | |||
11-104948611-A-G | not specified | Likely benign (Dec 19, 2022) | ||
11-104949648-G-T | not specified | Uncertain significance (Oct 26, 2021) | ||
11-104949740-G-T | not specified | Uncertain significance (Dec 06, 2024) | ||
11-104949777-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
11-104950996-T-G | not specified | Uncertain significance (Sep 13, 2023) | ||
11-104951064-C-T | not specified | Uncertain significance (Aug 01, 2022) | ||
11-104951089-T-C | not specified | Uncertain significance (Apr 06, 2024) | ||
11-104951922-T-C | not specified | Uncertain significance (Oct 12, 2024) | ||
11-104951974-C-G | not specified | Uncertain significance (Oct 14, 2023) | ||
11-104951975-T-C | not specified | Uncertain significance (Nov 18, 2022) | ||
11-104952002-T-A | not specified | Uncertain significance (Sep 29, 2023) | ||
11-104954755-T-C | not specified | Likely benign (May 26, 2022) | ||
11-104954785-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
11-104954797-A-G | not specified | Uncertain significance (May 17, 2023) | ||
11-104954812-C-T | not specified | Uncertain significance (Jun 10, 2022) | ||
11-104954870-C-T | Benign (Dec 31, 2019) | |||
11-104954880-C-A | not specified | Uncertain significance (Mar 02, 2023) | ||
11-104954881-T-C | not specified | Uncertain significance (Apr 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CASP4 | protein_coding | protein_coding | ENST00000444739 | 8 | 26571 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.05e-8 | 0.525 | 125521 | 1 | 204 | 125726 | 0.000816 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.176 | 201 | 208 | 0.966 | 0.0000107 | 2497 |
Missense in Polyphen | 57 | 68.298 | 0.83458 | 855 | ||
Synonymous | -1.32 | 88 | 73.5 | 1.20 | 0.00000384 | 691 |
Loss of Function | 1.01 | 14 | 18.7 | 0.747 | 9.80e-7 | 221 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000370 | 0.000369 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.00555 | 0.00551 |
European (Non-Finnish) | 0.000653 | 0.000642 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Inflammatory caspase (PubMed:7797510, PubMed:23516580, PubMed:25119034). Essential effector of NLRP3 inflammasome- dependent CASP1 activation and IL1B and IL18 secretion in response to non-canonical activators, such as UVB radiation, cholera enterotoxin subunit B and cytosolic LPS (PubMed:22246630, PubMed:26174085, PubMed:26173988, PubMed:26508369, PubMed:25964352). Independently of NLRP3 inflammasome and CASP1, promotes pyroptosis, through GSDMD cleavage and activation, and IL1A, IL18 and HMGB1 release in response to non-canonical inflammasome activators (PubMed:24879791, PubMed:25964352). Plays a crucial role in the restriction of Salmonella typhimurium replication in colonic epithelial cells during infection (PubMed:25121752). In later stages of the infection, LPS from cytosolic Salmonella triggers CASP4 activation, which ultimately results in pyroptosis of infected cells and their extrusion into the gut lumen, as well as in IL18 secretion. Pyroptosis limits bacterial replication, while cytokine secretion promotes the recruitment and activation of immune cells and triggers mucosal inflammation. Involved in LPS-induced IL6 secretion; this activity may not require caspase enzymatic activity (PubMed:26508369). Involved in cell death induced by endoplasmic reticulum stress and by treatment with cytotoxic APP peptides found Alzheimer's patient brains (PubMed:15123740, PubMed:22246630, PubMed:23661706). Activated by direct binding to LPS without the need of an upstream sensor (PubMed:25119034). Does not directly process IL1B (PubMed:7743998, PubMed:7797592, PubMed:7797510). During non- canonical inflammasome activation, cuts CGAS and may play a role in the regulation of antiviral innate immune activation (PubMed:28314590). {ECO:0000269|PubMed:15123740, ECO:0000269|PubMed:22246630, ECO:0000269|PubMed:23516580, ECO:0000269|PubMed:23661706, ECO:0000269|PubMed:24879791, ECO:0000269|PubMed:25119034, ECO:0000269|PubMed:25121752, ECO:0000269|PubMed:25964352, ECO:0000269|PubMed:26173988, ECO:0000269|PubMed:26174085, ECO:0000269|PubMed:26508369, ECO:0000269|PubMed:28314590, ECO:0000269|PubMed:7743998, ECO:0000269|PubMed:7797510, ECO:0000269|PubMed:7797592}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Apoptosis Modulation and Signaling;Apoptosis;Apoptotic Signaling Pathway;caspase cascade in apoptosis;internal ribosome entry pathway;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;DroToll-like;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.246
Intolerance Scores
- loftool
- 0.981
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.44
Haploinsufficiency Scores
- pHI
- 0.262
- hipred
- N
- hipred_score
- 0.318
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.909
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Casp4
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm;
Gene ontology
- Biological process
- proteolysis;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;inflammatory response;innate immune response;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;intrinsic apoptotic signaling pathway;execution phase of apoptosis;positive regulation of tumor necrosis factor-mediated signaling pathway;cellular response to amyloid-beta
- Cellular component
- extracellular region;cytoplasm;mitochondrion;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;plasma membrane;protein-containing complex;inflammasome complex
- Molecular function
- cysteine-type endopeptidase activity;CARD domain binding;cysteine-type endopeptidase activity involved in apoptotic process;cysteine-type endopeptidase activity involved in apoptotic signaling pathway